Insider Transactions in Q1 2022 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Dipal Doshi CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,250
+12.35%
|
-
|
|
Mar 01
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,006
+34.89%
|
-
|
|
Mar 01
2022
|
Nerissa Kreher Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,344
+39.96%
|
-
|
|
Mar 01
2022
|
Natarajan Sethuraman Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,588
+6.9%
|
-
|
|
Mar 01
2022
|
Nathan J Dowden President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,263
+13.43%
|
-
|
|
Jan 13
2022
|
Dipal Doshi CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.14%
|
$10,000
$1.74 P/Share
|
|
Jan 12
2022
|
John F Crowley Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$45,000
$9.71 P/Share
|